Solomon G E, Hilgartner M W, Kutt H
Neurol Neurocir Psiquiatr. 1977;18(2-3 Suppl):277-84.
A few neonates born to mothers receiving anticonvulsant drugs during pregnancy have shown defects in vitamin K dependent clotting factors with or without clinical bleeding. Experimentally, phenytoin (diphenyl hydantoin, DPH) has induced clotting defects in cats and inhibited production of clotting factors in rat liver slices. Phenobarbital has produced similar but milder defects. Anticonvulsants have been observed to produce clotting defects in 9 children, 2 weeks to 8 years in age. Elevated levels of phenytoin or other anticonvulsants, or a combination of anticonvulsants were measured in the children. Six patients were on drug combination including two or more of the following: phenytoin, phenobarbital, primidone, carbamazepine, diazepam, ethosuximide. Clotting defects included: elevated prothrombin time, elevated partial thromboplastin time, diminished factors V, VII or X. All children had neurologic symptoms of anticonvulsant toxicity, but the only hematologic problems were oozing from venipuncture sites and increased bruising in 3. All patients were on normal diets and had normal liver function tests. By lowering the level of anticonvulsants, clotting factors returned toward normal. Elevated levels of anticonvulsants can potentially produce clotting defects in neonates and young children.
一些在孕期母亲接受抗惊厥药物治疗的新生儿,无论有无临床出血症状,均出现了维生素K依赖性凝血因子缺陷。在实验中,苯妥英(二苯乙内酰脲,DPH)在猫身上诱发了凝血缺陷,并在大鼠肝切片中抑制了凝血因子的产生。苯巴比妥也产生了类似但较轻的缺陷。据观察,抗惊厥药物在9名年龄在2周至8岁的儿童中导致了凝血缺陷。这些儿童体内苯妥英或其他抗惊厥药物水平升高,或存在抗惊厥药物组合。6名患者使用了药物组合,包括以下两种或更多药物:苯妥英、苯巴比妥、扑米酮、卡马西平、地西泮、乙琥胺。凝血缺陷包括:凝血酶原时间延长、部分凝血活酶时间延长、因子V、VII或X减少。所有儿童均有抗惊厥药物毒性的神经症状,但唯一的血液学问题是静脉穿刺部位渗血,3名儿童出现瘀伤增多。所有患者饮食正常,肝功能检查正常。通过降低抗惊厥药物水平,凝血因子恢复正常。抗惊厥药物水平升高可能会在新生儿和幼儿中导致凝血缺陷。